Cargando…

Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome

BACKGROUND: In non-ST-segment elevation acute coronary syndrome (ACS), the likelihood of adverse events should be estimated. Guidelines recommend risk stratification models for that purpose. The Dante Pazzanese risk score (DANTE score) is a simple risk stratification model composed with the followin...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Elizabete Silva, Minuzzo, Luiz, de Souza, Roberta, Timerman, Ari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032298/
https://www.ncbi.nlm.nih.gov/pubmed/23949327
http://dx.doi.org/10.5935/abc.20130163
_version_ 1782317625465896960
author dos Santos, Elizabete Silva
Minuzzo, Luiz
de Souza, Roberta
Timerman, Ari
author_facet dos Santos, Elizabete Silva
Minuzzo, Luiz
de Souza, Roberta
Timerman, Ari
author_sort dos Santos, Elizabete Silva
collection PubMed
description BACKGROUND: In non-ST-segment elevation acute coronary syndrome (ACS), the likelihood of adverse events should be estimated. Guidelines recommend risk stratification models for that purpose. The Dante Pazzanese risk score (DANTE score) is a simple risk stratification model composed with the following variables: age increase (0 to 9 points); history of diabetes mellitus (2 points) or stroke (4 points); no use of angiotensin-converting-enzyme inhibitor (1 point); creatinine elevation (0 to 10 points); combination of troponin elevation and ST-segment depression (0 to 4 points). OBJECTIVE: To validate the DANTE score in patients with non-ST-segment elevation ACS. METHODS: Prospective, observational study including 457 patients, from September 2009 to October 2010. The patients were grouped in risk categories according to the original model score as follows: very low; low; intermediate; and high. The predictive ability of the score was assessed by using C-statistics. RESULTS: The sample comprised 291 (63.7%) men, the mean age being 62.1 years (SD=11.04). The event death or (re) infarction in 30 days was observed in 17 patients (3.7%). Progressive increase in the proportion of events was observed as the score increased: very low risk = 0.0%; low risk = 3.9%; intermediate risk = 10.9%; high risk = 60.0%; p < 0.0001. C-statistics was 0.87 (95% CI: 0.81-0.94; p < 0.0001). CONCLUSION: DANTE score showed an excellent capacity to predict the specific events, and can be incorporated to the prognostic assessment of patients with non-ST-segment elevation ACS.
format Online
Article
Text
id pubmed-4032298
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Sociedade Brasileira de Cardiologia
record_format MEDLINE/PubMed
spelling pubmed-40322982014-05-27 Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome dos Santos, Elizabete Silva Minuzzo, Luiz de Souza, Roberta Timerman, Ari Arq Bras Cardiol Original Article BACKGROUND: In non-ST-segment elevation acute coronary syndrome (ACS), the likelihood of adverse events should be estimated. Guidelines recommend risk stratification models for that purpose. The Dante Pazzanese risk score (DANTE score) is a simple risk stratification model composed with the following variables: age increase (0 to 9 points); history of diabetes mellitus (2 points) or stroke (4 points); no use of angiotensin-converting-enzyme inhibitor (1 point); creatinine elevation (0 to 10 points); combination of troponin elevation and ST-segment depression (0 to 4 points). OBJECTIVE: To validate the DANTE score in patients with non-ST-segment elevation ACS. METHODS: Prospective, observational study including 457 patients, from September 2009 to October 2010. The patients were grouped in risk categories according to the original model score as follows: very low; low; intermediate; and high. The predictive ability of the score was assessed by using C-statistics. RESULTS: The sample comprised 291 (63.7%) men, the mean age being 62.1 years (SD=11.04). The event death or (re) infarction in 30 days was observed in 17 patients (3.7%). Progressive increase in the proportion of events was observed as the score increased: very low risk = 0.0%; low risk = 3.9%; intermediate risk = 10.9%; high risk = 60.0%; p < 0.0001. C-statistics was 0.87 (95% CI: 0.81-0.94; p < 0.0001). CONCLUSION: DANTE score showed an excellent capacity to predict the specific events, and can be incorporated to the prognostic assessment of patients with non-ST-segment elevation ACS. Sociedade Brasileira de Cardiologia 2013-09 /pmc/articles/PMC4032298/ /pubmed/23949327 http://dx.doi.org/10.5935/abc.20130163 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
dos Santos, Elizabete Silva
Minuzzo, Luiz
de Souza, Roberta
Timerman, Ari
Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome
title Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome
title_full Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome
title_fullStr Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome
title_full_unstemmed Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome
title_short Prospective Validation of the Dante Pazzanese Risk Score in Non-STSegment Elevation Acute Coronary Syndrome
title_sort prospective validation of the dante pazzanese risk score in non-stsegment elevation acute coronary syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032298/
https://www.ncbi.nlm.nih.gov/pubmed/23949327
http://dx.doi.org/10.5935/abc.20130163
work_keys_str_mv AT dossantoselizabetesilva prospectivevalidationofthedantepazzaneseriskscoreinnonstsegmentelevationacutecoronarysyndrome
AT minuzzoluiz prospectivevalidationofthedantepazzaneseriskscoreinnonstsegmentelevationacutecoronarysyndrome
AT desouzaroberta prospectivevalidationofthedantepazzaneseriskscoreinnonstsegmentelevationacutecoronarysyndrome
AT timermanari prospectivevalidationofthedantepazzaneseriskscoreinnonstsegmentelevationacutecoronarysyndrome